Health

Prominent Stanford University scientist and cellular reprogramming innovator will oversee all research for Turn Bio

Vittorio Sebastiano, globally recognized for pioneering science, expands his role at company he co-founded as it moves closer to clinical research Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that co-founder Vittorio Sebastiano, PhD, will become its head of research. Sebastiano led development of the unique […]

thaipr.net

9 ส.ค. 65

HISTORY OF HYPERTENSIVE DISORDERS DURING PREGNANCY LINKED TO INCREASED RISK OF DEMENTIA

Experiences of high blood pressure disorders during pregnancy are associated with an increased risk of vascular dementia and accelerated brain aging, according to studies reported today at the Alzheimer’s Association International Conference® (AAIC®) 2022 in San Diego and virtually. Hypertensive disorders of pregnancy (HDP) — conditions of high blood pressure including chronic/gestational hypertension and preeclampsia — have been…

thaipr.net

4 ส.ค. 65

HIGHLIGHTS FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2022

New research reported at the Alzheimer’s Association International Conference® (AAIC®) 2022 covered the breadth of Alzheimer’s and dementia research, including the basic biology of aging and the brain, risk factors and prevention strategies, and caregiving and living well with the disease. AAIC is the premier annual forum for presentation and discussion of the latest Alzheimer’s and dementia […]

thaipr.net

4 ส.ค. 65

Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination

Preclinical data support the potential of ONA-XR plus estrogen receptor degraders in endocrine resistant disease models Context to initiate Phase 1b/2 clinical trial in Q4 2022 Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, and The Menarini Group (“Menarini”)…

thaipr.net

3 ส.ค. 65

Pharming Announces New ICD-10-CM Code for APDS, a Rare Primary Immunodeficiency

Implemented by the Centers for Disease Control and Prevention, the diagnosis code will accurately identify US patients with APDS, supporting care and research efforts Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that a new diagnosis code for reporting cases of activated phosphoinositide 3-kinase delta syndrome (APDS), a rare primary immunodeficiency, […]

thaipr.net

3 ส.ค. 65

iHerb Achieves Customer Service Milestones

Users Highly Rate iHerb on Top Online Platforms iHerb, the world’s largest e-commerce platform dedicated to health and wellness, reached significant milestones last month. The company is excited to announce its ratings among Google Customers, Google Play Store, and the Apple App Store. With a 4.9 star rating on Google, 4.8 on Google Play Store and Apple App […]

thaipr.net

3 ส.ค. 65

LOWER SOCIOECONOMIC STATUS IN CHILDHOOD, PERSISTENT LOW WAGES LINKED TO RISK FOR DEMENTIA AND FASTER MEMORY DECLINE

Socioeconomic deprivation, including neighborhood disadvantages and persistent low wages, are associated with higher dementia risk, lower cognitive performance and faster memory decline, according to several studies reported today at the Alzheimer’s Association International Conference® (AAIC®) 2022 in San Diego and virtually. Socioeconomic status (SES) — reflecting both social and economic measures of a person’s work experience, and…

thaipr.net

3 ส.ค. 65

สุขภาพดี ในเดือนเกิด Birthday Check Up กับโรงพยาบาลธนบุรี 2

พบกับ แพ็กเกจตรวจสุขภาพ Birthday Check Up ตรวจทั้งหมด 16 รายการ ราคาพิเศษ 2,590 บาท (ราคาปกติ 5,675 บาท)  ตั้งแต่วันนี้ถึง 30 ธันวาคม 2565 รับสิทธิพิเศษกับรายการตรวจเพิ่มเติมลด 50% *กรุณางดน้ำ…

thaipr.net

2 ส.ค. 65
1 … 63 64 65 66 67 … 128

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.